US Stock MarketDetailed Quotes
PHIO Phio Pharmaceuticals
- 5.0500
- -0.7950-13.60%
Close Jul 12 16:00 ET
- 5.3959
- +0.3459+6.85%
Post 19:39 ET
2.58MMarket Cap-222P/E (TTM)
5.7000High5.0300Low24.83KVolume5.6900Open5.8450Pre Close134.69KTurnover4.90%Turnover RatioLossP/E (Static)510.19KShares29.070052wk High0.46P/B2.56MFloat Cap4.500052wk Low--Dividend TTM506.32KShs Float3118.4994Historical High--Div YieldTTM11.46%Amplitude4.5000Historical Low5.4250Avg Price1Lot Size
Phio Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -28.33%6.48M | -27.93%8.49M | -27.93%8.49M | -41.96%8.41M | -37.25%11.31M | -55.84%9.04M | -51.03%11.78M | -51.03%11.78M | -45.40%14.48M | -38.76%18.02M |
| -Cash and cash equivalents | -28.33%6.48M | -27.93%8.49M | -27.93%8.49M | -41.96%8.41M | -37.25%11.31M | -55.84%9.04M | -51.03%11.78M | -51.03%11.78M | -45.40%14.48M | -38.76%18.02M |
| Restricted cash | ---- | --0 | --0 | 0.00%50K | 0.00%50K | 0.00%50K | 0.00%50K | 0.00%50K | 0.00%50K | 0.00%50K |
| Other current assets | 16.93%373K | 35.28%832K | 35.28%832K | 3.32%871K | -58.10%678K | -72.45%319K | -0.81%615K | -0.81%615K | -3.21%843K | -3.69%1.62M |
| Total current assets | -27.18%6.85M | -25.10%9.32M | -25.10%9.32M | -39.34%9.33M | -38.87%12.04M | -56.60%9.4M | -49.67%12.45M | -49.67%12.45M | -43.98%15.38M | -36.81%19.69M |
| Non current assets | ||||||||||
| Net PPE | -99.33%2K | -88.66%39K | -88.66%39K | -46.67%208K | -40.56%255K | -36.54%297K | -17.31%344K | -17.31%344K | -16.31%390K | -11.36%429K |
| -Gross PPE | -99.33%2K | -22.65%1.18M | -22.65%1.18M | -46.67%208K | -40.56%255K | -36.54%297K | -0.13%1.52M | -0.13%1.52M | -16.31%390K | -11.36%429K |
| -Accumulated depreciation | ---- | 3.32%-1.14M | 3.32%-1.14M | ---- | ---- | ---- | -6.33%-1.18M | -6.33%-1.18M | ---- | ---- |
| Other non current assets | -50.00%3K | -87.50%3K | -87.50%3K | -87.50%3K | -77.78%6K | -77.78%6K | -11.11%24K | -11.11%24K | -11.11%24K | 50.00%27K |
| Total non current assets | -98.35%5K | -88.59%42K | -88.59%42K | -49.03%211K | -42.76%261K | -38.79%303K | -16.93%368K | -16.93%368K | -16.02%414K | -9.16%456K |
| Total assets | -29.40%6.85M | -26.92%9.36M | -26.92%9.36M | -39.59%9.54M | -38.96%12.3M | -56.20%9.71M | -49.09%12.81M | -49.09%12.81M | -43.49%15.79M | -36.37%20.14M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -64.52%320K | -15.66%657K | -15.66%657K | -68.14%173K | -44.16%641K | 174.16%902K | 175.27%779K | 175.27%779K | 68.63%543K | 229.89%1.15M |
| -accounts payable | -64.52%320K | -15.66%657K | -15.66%657K | -68.14%173K | -44.16%641K | 174.16%902K | 175.27%779K | 175.27%779K | 68.63%543K | 229.89%1.15M |
| Current accrued expenses | -31.49%929K | 16.69%720K | 16.69%720K | 37.13%2.08M | -6.37%1.65M | -35.95%1.36M | -70.45%617K | -70.45%617K | -26.30%1.52M | -16.64%1.76M |
| Current debt and capital lease obligation | ---- | -74.07%35K | -74.07%35K | -46.97%70K | -20.00%104K | 8.66%138K | 8.00%135K | 8.00%135K | 17.86%132K | 8.33%130K |
| -Current capital lease obligation | --0 | -74.07%35K | -74.07%35K | -46.97%70K | -20.00%104K | 8.66%138K | 8.00%135K | 8.00%135K | 17.86%132K | 8.33%130K |
| Current liabilities | -47.87%1.25M | -15.73%1.63M | -15.73%1.63M | 6.02%2.33M | -21.24%2.39M | -6.88%2.4M | -36.80%1.94M | -36.80%1.94M | -12.06%2.19M | 17.80%3.04M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | --0 | --0 | --0 | --0 | --0 | -79.41%35K | -79.41%35K | -65.35%70K | -55.56%104K |
| -Long term capital lease obligation | ---- | --0 | --0 | --0 | --0 | --0 | -79.41%35K | -79.41%35K | -65.35%70K | -55.56%104K |
| Preferred securities outside stock equity | ---- | --0 | --0 | --0 | --0 | --0 | --2K | --2K | ---- | ---- |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | -78.24%37K | -78.24%37K | -65.35%70K | -55.56%104K |
| Total liabilities | -47.87%1.25M | -17.31%1.63M | -17.31%1.63M | 2.74%2.33M | -23.85%2.39M | -11.62%2.4M | -38.97%1.98M | -38.97%1.98M | -16.05%2.26M | 11.70%3.14M |
| Shareholders'equity | ||||||||||
| Share capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 0.00%1K | 0.00%1K |
| -common stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 0.00%1K | 0.00%1K |
| -Preferred stock | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 | --0 |
| Retained earnings | -7.11%-141.36M | -8.43%-139.21M | -8.43%-139.21M | -9.28%-137.31M | -10.21%-134.53M | -10.41%-131.98M | -9.82%-128.38M | -9.82%-128.38M | -10.75%-125.65M | -11.27%-122.07M |
| Paid-in capital | 5.51%146.96M | 5.54%146.94M | 5.54%146.94M | 3.84%144.52M | 3.85%144.44M | 0.22%139.29M | 0.28%139.22M | 0.28%139.22M | 0.35%139.18M | 0.38%139.08M |
| Total stockholders'equity | -23.35%5.6M | -28.68%7.73M | -28.68%7.73M | -46.68%7.21M | -41.75%9.9M | -62.41%7.31M | -50.58%10.84M | -50.58%10.84M | -46.42%13.53M | -41.05%17M |
| Total equity | -23.35%5.6M | -28.68%7.73M | -28.68%7.73M | -46.68%7.21M | -41.75%9.9M | -62.41%7.31M | -50.58%10.84M | -50.58%10.84M | -46.42%13.53M | -41.05%17M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg